Home ›
Trademark Categories ›
Pharmaceuticals ›
2022 ›
AR ›
ARNATAR THERAPEUTICS CURE FOR CAUSE
Trademark search for:
ARNATAR THERAPEUTICS CURE FOR CAUSE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2022-09-16 — Application filed
2022-09-20 — Application filed
2022-10-04 — Application filed
2022-10-05 — Notice of design search code e-mailed
2023-06-28 — Assigned to examiner
2023-06-29 — Final disposition recorded
2023-06-29 — Final disposition recorded
2023-06-29 — Final disposition recorded
2023-08-15 — Office action issued
2023-08-15 — Correspondence received in law office
2023-08-16 — Teas/email correspondence entered
2023-08-17 — Approved for pub - principal register
2023-09-06 — Notification of notice of publication e-mailed
2023-09-26 — Published for opposition
2023-09-26 — Official gazette publication confirmation e-mailed
2023-11-16 — Teas post publication amendment received
2023-11-21 — Noa e-mailed - sou required from applicant
2023-12-20 — Assigned to petition staff
2023-12-22 — Post publication amendment - entered
2023-12-23 — Corrected noa e-mailed
2024-05-14 — Sou teas extension received
2024-05-14 — Sou extension 1 filed
2024-05-14 — Sou extension 1 granted
2024-05-15 — Notice of approval of extension request e-mailed
2024-11-13 — Sou teas extension received
2024-11-13 — Sou extension 2 filed
2024-12-30 — Case assigned to intent to use paralegal
2025-01-03 — Sou extension 2 granted
2025-01-03 — Notice of approval of extension request e-mailed
2025-05-20 — Sou teas extension received
2025-05-20 — Sou extension 3 filed
2025-05-21 — Sou extension 3 granted
2025-05-21 — Notice of approval of extension request e-mailed
2025-12-22 — Application abandoned
2025-12-22 — Application abandoned
2025-12-22 — Final status recorded
Owner Information
Arnatar Therapeutics, Inc.
Arnatar Therapeutics
Correspondent
Andrew T. Rissler Patel & Almeida, P.C.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
